60
600055.SHG Beijing Wandong Medical Technology Co Ltd
- Market cap
- CNY 7.47B
- P/E
- -
- P/B
- 1.72x
- ROE
- -4.5%
- Dividend yield
- 1.22%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 600055.SHG undervalued?
Graham numberThe Graham number of Beijing Wandong Medical Technology Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Beijing Wandong Medical Technology Co Ltd fundamental analysis
No fundamental analysis for Beijing Wandong Medical Technology Co Ltd yet.
Beijing Wandong Medical Technology Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Beijing Wandong Medical Technology Co Ltd
Beijing Wandong Medical Technology Co.,Ltd. engages in the research, development, manufactures, sales, and after-sale services of digital imaging equipment in China. It operates through two segments Medical Equipment Sales Business; and Medical Services and Others. The company provides digital X radiography system (DR), including panorama DR; magnetic resonance imaging system (MRI) for clinical magnetic resonance imaging; X-ray computed tomography system (CT) for clinical X-…
Full company profileBeijing Wandong Medical Technology Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Beijing Wandong Medical Technology Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 813M | 884M | 955M | 982M | 1.13B | 1.16B | 1.12B | 1.24B | 1.52B | 1.34B | 1.70B |
| Gross Profit | 309M | 360M | 410M | 456M | 556M | 522M | 491M | 517M | 551M | 325M | 419M |
| Operating Income | 49.3M | 117M | 177M | 189M | 264M | 209M | 193M | 213M | 163M | -371M | -173M |
| EBITDA | 115M | 155M | 213M | 231M | 306M | 244M | 226M | 248M | 203M | -322M | -195M |
| Net Income | 71.5M | 109M | 153M | 169M | 221M | 183M | 175M | 189M | 157M | -228M | -192M |
| EPS | 0.13 | 0.20 | 0.28 | 0.31 | 0.41 | 0.34 | 0.27 | 0.27 | 0.22 | -0.32 | -0.27 |
| Balance Sheet | |||||||||||
| Total Assets | 2.20B | 2.32B | 2.44B | 2.57B | 2.86B | 2.88B | 5.26B | 5.40B | 5.47B | 5.76B | 5.19B |
| Total Liabilities | 346M | 420M | 422M | 383M | 480M | 373M | 552M | 576M | 593M | 1.18B | 792M |
| Shareholders' Equity | 1.79B | 1.84B | 1.96B | 2.09B | 2.28B | 2.40B | 4.61B | 4.71B | 4.77B | 4.46B | 4.29B |
| Cash & Short-term Investments | 751M | 538M | 350M | 736M | 1.17B | 1.13B | 3.34B | 3.44B | 3.59B | 3.27B | 2.58B |
| Total Debt | 4.20M | 4.20M | 4.20M | 434K | 82.9M | 19.0M | 22.6M | 17.6M | 26.5M | 438M | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 103M | -77.7M | 75.5M | 94.8M | 520M | 89.7M | 185M | 208M | 218M | -252M | - |
| Capital Expenditure | 21.4M | 50.9M | 42.6M | 41.4M | 23.1M | 11.9M | 14.0M | 17.1M | 38.6M | 99.0M | 83.9M |
| Free Cash Flow | 81.4M | -129M | 32.9M | 53.4M | 497M | 77.9M | 171M | 191M | 180M | -351M | -363M |
| Ratios | |||||||||||
| ROE | 4.0% | 5.9% | 7.8% | 8.1% | 9.7% | 7.6% | 3.8% | 4.0% | 3.3% | -5.1% | -4.5% |
| ROA | 3.2% | 4.7% | 6.3% | 6.6% | 7.7% | 6.4% | 3.3% | 3.5% | 2.9% | -4.0% | -3.7% |
| Net Profit Margin | 8.8% | 12.3% | 16.1% | 17.2% | 19.5% | 15.8% | 15.6% | 15.2% | 10.3% | -17.0% | -11.3% |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.04x | 0.01x | 0.00x | 0.00x | 0.01x | 0.10x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Beijing Wandong Medical Technology Co Ltd dividends
- Dividend yield
- 1.22%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 16, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 91.4M | 0.13 | - |
| 2024 | CNY 91.4M | 0.13 | 58.1% |
| 2023 | CNY 84.4M | 0.12 | 44.7% |
| 2022 | CNY 70.3M | 0.11 | 40.1% |
| 2021 | CNY 69.7M | 0.13 | 38.0% |
| 2020 | CNY 26.8M | 0.05 | 12.1% |
| 2019 | CNY 54.0M | 0.10 | 31.9% |
| 2018 | CNY 27.0M | 0.05 | 17.6% |
| 2017 | CNY 57.9M | 0.11 | 53.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 14:10 on Jun 2, 2017.
Who owns Beijing Wandong Medical Technology Co Ltd
- Insiders 51.45%
- Institutions 3.89%
- Public & others 44.66%
- Shares outstanding 703M
- Free float 361M
Beijing Wandong Medical Technology Co Ltd company profile
- Company name
- Beijing Wandong Medical Technology Co Ltd
- Ticker
- 600055.SHG
- ISIN
- CNE000000PZ1
- Exchange
- Shanghai Stock Exchange
- Listed since
- Apr 24, 1997
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,215
- Fiscal year end
- December
- Address
- Building 3, Beijing, China, 100015
- Phone
- 86 10 8456 9688
- Website
- wandong.com.cn
About Beijing Wandong Medical Technology Co Ltd
Beijing Wandong Medical Technology Co.,Ltd. engages in the research, development, manufactures, sales, and after-sale services of digital imaging equipment in China. It operates through two segments Medical Equipment Sales Business; and Medical Services and Others. The company provides digital X radiography system (DR), including panorama DR; magnetic resonance imaging system (MRI) for clinical magnetic resonance imaging; X-ray computed tomography system (CT) for clinical X-ray; vascular interventional therapy system (DSA) for clinical examination and interventional treatment of cardiovascular, cerebrovascular, peripheral vascular, and other diseases; flat panel gastrointestinal diagnostic system; digital flat panel breast system; and mobile x-ray machine. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. Beijing Wandong Medical Technology Co.,Ltd. company was founded in 1955 and is headquartered in Beijing, China.
Beijing Wandong Medical Technology Co Ltd management
5- Mr. Jinsong SongPresident & Director · born 1967
- Mr. Xiaoquan JingVP & CFO · born 1969
- Ms. Yunbin OuCompany Secretary & Head of Investor Relations · born 1988
- Mr. Jiaxiang HuangVice President · born 1978
- Zheng YangAccounting Supervisor